HGYN 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-06-22

• Revenue was $43,697 in the three months ended March 31, 2026 compared to $184,492 in the same period last year. The decrease in revenue was mainly because the decline in Chinese VIEs revenue.

• As of March 31, 2026 and December 31, 2025, we had a cash balance of $6,444 and $16,747 respectively. During the three months ended March 31, 2026 and 2025, the company’s operations are primarily funded by the Company’s CEO and major shareholder and the minority owners of the Chinese VIEs.

• For the three months ended March 31, 2026, net cash used in operating activities was $3,420. This was primarily due to the net loss of $94,471, adjusted by non-cash related expenses of $2,088 which consisted primarily of depreciation and amortization expenses, and then decreased by favorable changes…

• For the three months ended March 31, 2026, net cash used in investing activities was developing spending of $7,079 on software.

• The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, we had a net loss of $94,471 for the three months ended March 31, 2026 and a net income of $37,357 for the three months ended March …

相对上期删除的文字 · 来源:10-Q · 2025-11-19

• Revenue was $258,329 in the three months ended September 30, 2025 compared to $85 in the same period last year. The increase in revenue was mainly because the Chinese VIEs started generating revenue in the second quarter of 2024 and have been ramping up the operations to generate more revenues.

• Results of Operations for the Nine Months Ended September 30, 2025 compared to the Nine Months Ended September 30, 2024

• Revenue was $612,206 in the nine months ended September 30, 2025 compared to $15,290 in the same period last year. The increase in revenue was mainly because the Chinese VIEs started generating revenue in the second quarter of 2024 and have been ramping up the operations to generate more revenues.

• Cost of goods sold was $221,917 in the nine months ended September 30, 2025 compared to $6,179 in the same period last year due to the increase in revenue.

• Operating expenses were $256,498 in the nine months ended September 30, 2025 compared to $129,023 in the same period last year, an increase of $127,475 or 98.8%. The increase was mainly due to the increase in general and administrative expenses, selling and marketing expenses, and professional fees.…